News
Clinical data builds with CR in testicular cancer, enrollment in Phase 2 gastric trial, and new data in PD-1–resistant tumors ...
A project from Metro Boomin and Curren$y is in the works. The rapper/producer duo took to social media to tease the arrival ...
Drake starred in an ad for his “Summer Mink” fragrance, with the short clip posted to his Instagram. The video sees the ...
Q1 2025 Earnings Call Transcript May 15, 2025 Operator: Thank you for standing by. My name is Rochelle, and I will be your ...
Analysts are estimating that MiNK Therapeutics will report an earnings per share (EPS) of $-0.71. MiNK Therapeutics bulls ...
In their usual habitat, fish are a major food, caught in the water after a brief chase. On land, mink will kill prey larger ...
MiNK Therapeutics Inc (INKT) showcases promising clinical progress and strategic partnerships while navigating financial constraints and funding delays.
MiNK Therapeutics, Inc. announced its first-quarter 2025 financial results and highlighted significant progress in its development of allogeneic invariant natural killer T (iNKT) cell therapies.
6d
inews.co.uk on MSNGiant hogweed and American mink destroying nature spots due to Defra cutsNew mapping of Sites of Scientific Interest across England and Wales has revealed thousands of sightings of non-native ...
Discover MiNK Therapeutics' Q1 2025 progress in iNKT cell therapies, strategic partnerships, reduced cash burn, and upcoming clinical milestones.
This long and slender animal was not a muskrat. It was a mink! The pond was one of the manmade landscape features that had ...
NEW YORK, May 15, 2025 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf invariant natural ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results